Cite
Genome sequencing for nonsmall-cell lung cancer identifies a basis for nintedanib sensitivity
MLA
Kazuhiko Nakagawa, et al. “Genome Sequencing for Nonsmall-Cell Lung Cancer Identifies a Basis for Nintedanib Sensitivity.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 27, no. 4, Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7989bd9b2561098ddb572411c40252d&authtype=sso&custid=ns315887.
APA
Kazuhiko Nakagawa, Hidetoshi Hayashi, Kazuko Sakai, K. Okamoto, Kaoru Tanaka, Masayuki Takeda, Kazuto Nishio, & T. Shimizu. (2016). Genome sequencing for nonsmall-cell lung cancer identifies a basis for nintedanib sensitivity. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 27(4).
Chicago
Kazuhiko Nakagawa, Hidetoshi Hayashi, Kazuko Sakai, K. Okamoto, Kaoru Tanaka, Masayuki Takeda, Kazuto Nishio, and T. Shimizu. 2016. “Genome Sequencing for Nonsmall-Cell Lung Cancer Identifies a Basis for Nintedanib Sensitivity.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 27 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7989bd9b2561098ddb572411c40252d&authtype=sso&custid=ns315887.